Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
nicotine polacrilex, Quantity: 20 mg (Equivalent: nicotine, Qty 4 mg)
Johnson & Johnson Pacific Pty Ltd
Gum, chewing
Excipient Ingredients: glycerol; sorbitol; quinoline yellow; sodium carbonate; Flavour; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; glycerol ester of gum rosin; glycerol ester of polymerised rosin; microcrystalline wax; mono- and di- glycerides
Buccal, Oral
315 piece pack size, 385 piece pack size, 225 piece pack size, 310 piece pack size, 150 piece pack size, 370 piece pack size, 75
Not scheduled. Not considered by committee
For the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus facilitating smoking cessation in smokers motivated to quit. In smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy as a step towards stopping completely.
Visual Identification: Square yellowish pieces, 14.5mm x 14.5mm x approx 5.4mm.; Container Type: Blister Pack; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius
Registered
1991-08-13